The purpose of this site is to collect lab research by medical doctors about herbs that are proven to treat illnesses and counter the false attacks on herbs by the medical industry and false claims by alternative medicine. I let the science tell the facts.
index sitemap advanced
search engine by freefind
Turmeric (Curcummin)

Few recognize that an organ in the body can be repaired. Turmeric is proven by these medical research reports to help and or heal cirrhosis of the liver. 1-4. Prostrate cancer 5, breast cancer 6,7, Irritable Bowel. 8. glucose improvement. 9.significantly lowered the lipid peroxide levels in the ... liver. 10. aids anemia of cancer and chronic disease. 11.antifibrotic and fibrolitic drug in the treatment of chronic hepatic disease. 12. obesity-related metabolic diseases

Most of the reports indicate Turmeric increased Kappa B which is the factor that regulates the body's ability to reverse oxidative stress. This is reported in many of the reports below. Diabetes see 8 and 9.

The healing effects reported in these reports are phenomenal and if it were a patented drug it would be front page news with prolific TV ads. Ask your doctor why they are not telling you about the healing properties of Turmeric with Dr lab proof.

1. "...These results provide novel insights into therapeutic mechanisms of curcumin in inhibiting HSC activation and intervening liver fibrogenesis associated with hyperleptinemia in NASH patients.

2. "...These results confirm and extend our prior in vitro observations and provide novel insights into the mechanisms of curcumin in the protection of the liver. Our results suggest that curcumin might be a therapeutic antifibrotic agent for the treatment of hepatic fibrosis.

3. "...Curcumin inhibited the development of TAA-induced liver cirrhosis mainly due to its anti-inflammatory activities and not by a direct anti-fibrotic effect. As curcumin ingestion is safe in humans, it may be reasonable to assess in clinical studies the beneficial effect of curcumin in slowing the development of liver cirrhosis."

4. "...CONCLUSION: The MED for liposomal curcumin is 20 mg/kg given once daily three times per week to achieve optimal tumor growth inhibition. This was dose recommended for additional preclinical studies to define safety and tolerability of liposomal curcumin in rat and dog models."

5. "...Our finding extrapolates the antitumor activity of curcumin in mediating the breast cancer cell proliferative rate and invasion by down-regulating the NFkappaB inducing genes."

6. "Curcumin has bright prospects for the treatment of inflammatory bowel disease...Further, curcumin significantly reduced clinical relapse in patients with quiescent IBD. The inhibitory effects of curcumin on major inflammatory mechanisms like COX-2, LOX, TNF-alpha, IFN-gamma, NF-kappaB and its unrivalled safety profile suggest that it has bright prospects in the treatment of IBD. However, randomized controlled clinical investigations in large cohorts of patients are needed to fully evaluate the clinical potential of curcumin."

7. "...These results suggest that curcuminoids exhibit a protective effect by accelerating antioxidant defense mechanisms and attenuating mitochondrial dysfunction in the brain of diabetic rats. Curcuminoids thus may be used as a promising therapeutic agent in preventing and/or delaying the progression of diabetic complications in the brain." If a drug did this it would be all over the news.

8. "...CONCLUSION: Improvement is due to slow release of glucose by fiber in the gastrointestinal track and short-chain fatty acid production from fiber by colon microbes."

9. "Pub Med 18940397  "Curcumin significantly lowered the lipid peroxide levels in the ... liver... "

10. "...These results demonstrate that curcumin has the potential to affect systemic iron metabolism, particularly in a setting of subclinical iron deficiency. This may affect the use of curcumin in patients with marginal iron stores or those exhibiting the anemia of cancer and chronic disease.."

11. "...These data suggest that curcumin might be an effective antifibrotic and fibrolitic drug in the treatment of chronic hepatic diseases.."

12. "'New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases...A metabolic abnormality such as obesity is a major obstacle in the maintenance of the human health system and causes various chronic diseases including type 2 diabetes, hypertension, cardiovascular diseases, as well as various cancers...CONCLUSION:...Furthermore, the relatively low cost of curcumin, safety and proven efficacy make it advisable to include curcumin as part of healthy diet. Metabolic diseases are the same as KappaB or NF-kB


Recommended Information